[1]
M. Rymbai and V. V. Borah, “Impact of the revised CLSI M100 (36th edition, 2026) minimum inhibitory concentration breakpoints on antimicrobial susceptibility interpretation and multidrug-resistance classification of clinical Pseudomonas aeruginosa isolates: a retrospective study”, Int J Basic Clin Pharmacol, vol. 15, no. 5, pp. 1002–1009, Aug. 2026.